Cai et al., 2007 - Google Patents
Identification of a cysteine-histidine thioether bridge bond in functional units d, e and f of β</inf> c<//inf>-haemocyanin of the gastropod Helix pomatiaCai et al., 2007
- Document ID
- 15655725878448360236
- Author
- Cai H
- Gielens C
- Préaux G
- Publication year
- Publication venue
- Pharmaceutical Biotechnology
External Links
- 241000237369 Helix pomatia 0 title abstract description 4
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McCarthy et al. | Carbamylation of Proteins in 2-D Electrophoresis Myth or Reality? | |
| CL2014001334A1 (en) | A binding protein, antibodies or fragments thereof that binds to her-3; nucleic acid molecule that encodes it; production procedure; pharmaceutical composition that includes it; its use to treat diseases associated with her -3; and method of diagnosis of a disease (div. sol. 3748-2006). | |
| EA200801509A1 (en) | HUMAN MONOCLONAL ANTIBODIES TO PROTEINTHYROSINKINASE 7 (PTK7) AND METHODS OF APPLICATION OF ANTIBODIES AGAINST PTK7 | |
| MX2008009886A (en) | Antibodies that bind par-2. | |
| CL2008000935A1 (en) | Anti-ige human monoclonal antibody or fragment thereof; nucleic acid encoding it; vector and host cell; Preparation method; pharmaceutical composition that includes it; and its use in the treatment of disorders related to ige. | |
| MX2010002716A (en) | Neuroendocrine factors for treatment of degenerative diseases. | |
| DK2004688T4 (en) | Enhanced selective protofibril antibodies and their use | |
| NO20075635L (en) | Antigen-binding molecules that have modified Fc regions and altered binding to Fc receptors | |
| NO20083793L (en) | Antibodies to amyloid-beta peptide | |
| ATE510011T1 (en) | NEW FUNGAL PROTEINS AND THE NUCLEIC ACIDS THAT ENCOD THEM | |
| BRPI0713000A8 (en) | SINGLE CHAIN MULTIESPECIFIC BINDING PROTEIN, PHARMACEUTICAL COMPOSITION AND USE OF SAID SINGLE CHAIN MULTIESPECIFIC BINDING PROTEIN | |
| CR20150016A (en) | MONOCLONAL ANTIBODY | |
| BRPI0806328B8 (en) | isolated antibody or antigen-binding fragment thereof, its method of preparation, pharmaceutical composition, polynucleotide, expression vector, as well as its uses | |
| GEP20125385B (en) | Antibodies directed against amyloid-beta peptide and methods using same | |
| MX350962B (en) | Method for making antibody fc-heterodimeric molecules using electrostatic steering effects. | |
| WO2006083964A3 (en) | Modified fusion molecules for treatment of allergic disease | |
| SE0400274D0 (en) | New polypeptide | |
| WO2007064727A3 (en) | Penetrabodies: receptor-mediated targeted delivery of functionally-active human antibody fragments into cytosol for the treatment of chronic infections and diseases | |
| WO2007039256A3 (en) | Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use | |
| ECSP066431A (en) | NOGO-A UNION MOLECULES AND PHARMACEUTICAL USE OF THE SAME | |
| JO3188B1 (en) | Antigen binding proteins specific for serum amyloid p component | |
| BR0316476A (en) | Composition and process for treating lupus nephritis | |
| DK1572745T3 (en) | Antibody anti-human NogoA and its pharmaceutical use | |
| BR112013023978A2 (en) | "Heat shock protein affinity polypeptide and its use in the diagnosis of infectious disease, immune response production and treatment of cancer, as well as nucleic acid, substance composition and fractionation method for clinical sample research or analysis." | |
| Wu et al. | Influence of disulfide connectivity on structure and bioactivity of α-conotoxin TxIA |